checkAd

     249  0 Kommentare Kitov Pharma Provides Update on Planned U.S. Launch of Consensi and Provides Three-Year Revenue Forecast - Seite 3

    Avoid taking Consensi after a recent heart attack, unless your healthcare provider tells you to. You may have an increased risk of another heart attack if you take NSAIDs after a recent heart attack.

    • Increased risk of bleeding, ulcers, and tears (perforation) of the esophagus (tube leading from the mouth to the stomach), stomach, and intestines:
    • anytime during use
    • without warning symptoms
    • that may cause death

    The risk of getting an ulcer or bleeding increases with:

    • past history of stomach ulcers, or stomach or intestinal bleeding with use of NSAIDs
    • taking medicines called “corticosteroids”, “antiplatelet drugs”, “anticoagulants”, “selective serotonin reuptake inhibitors (SSRIs)”, or “serotonin norepinephrine reuptake inhibitors (SNRIs)”
    • increasing doses of NSAIDs
    • older age
    • longer use of NSAIDs
    • poor health
    • smoking
    • advanced liver disease
    • drinking alcohol
    • bleeding problems

    You should not take other medicines that contain NSAIDs or salicylates during treatment with Consensi because of increased risk of stomach problems. Taking other medicines that contain NSAIDs or salicylates during treatment with Consensi will not provide increased relief of symptoms of osteoarthritis.

    Consensi should only be used:

    •  exactly as prescribed

    •  at the lowest dose possible for your treatment

    •  for the shortest time needed

    Who should not take Consensi?

    Do not take Consensi:

    • if you are allergic to amlodipine, celecoxib or any of the inactive ingredients in Consensi.
    • if you have had an asthma attack, hives, or other allergic reaction with aspirin or any other NSAIDs.
    • right before or after heart bypass surgery.
    • if you have had an allergic reaction to sulfonamides.

    Before taking Consensi, tell your healthcare provider about all your medical conditions, including if you:

    Seite 3 von 6



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Kitov Pharma Provides Update on Planned U.S. Launch of Consensi and Provides Three-Year Revenue Forecast - Seite 3 Company’s marketing partners in the U.S. plan to commence selling Consensi in May 2020Kitov expects to receive between $28 million and $36 million in milestone and royalty revenues from 2020 through 2022 TEL AVIV, Israel, March 12, 2020 (GLOBE …